Minoxidil, which was first commercialized by Rogaine in 1988, remains the only topical ingredient FDA-approved for treatment of adrogenetic alopecia. While many other brands have now adopted the ingredient — and lean into a lower price point to compete — Rogaine continues to be a top shareholder. Rogaine's core men's and women's minoxidil offerings.Courtesy The Kenvue-owned brand is best known for its Men's 5% Minoxidil Foam, which most retailers sell for $60 for a three-pack.